Free tool
Oncology stocks
We cover 8 companies grouped under the Oncology theme. The median market value in the group is $72.53M. Across the group, the median move over the past trading day is −2.09%. Price change over the past year runs from −80.7% to +327.3% across the middle 80 percent of the group, with a median of −36.9%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
8 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| NRIX | Nurix Therapeutics, Inc. | $2.73B | Mid cap | +178.70% | Oct 8, 2026 |
| NANO.PA | Nanobiotix S.A. | $2.12B | Mid cap | +341.09% | Sep 29, 2026 |
| NBTX | Nanobiotix S.A. | $2.11B | Mid cap | +321.42% | Sep 29, 2026 |
| OSE.PA | OSE Immunotherapeutics SA | $88.77M | Micro cap | −47.82% | Sep 28, 2026 |
| IMMP | Immutep Limited | $56.28M | Micro cap | −77.54% | Sep 2, 2026 |
| 0RAD.L | OSE Immunotherapeutics SA | $51.87M | Micro cap | −48.92% | Sep 28, 2026 |
| BLRX | BioLineRx Ltd. | $12.45M | Micro cap | −25.97% | Aug 31, 2026 |
| LNAI | Lunai Bioworks Inc. | $9.97M | Micro cap | −87.99% | Sep 28, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.